Benzenesulfonamides Incorporating Hydantoin Moieties Effectively Inhibit Eukaryoticand Human Carbonic Anhydrases

Int J Mol Sci. 2022 Nov 15;23(22):14115. doi: 10.3390/ijms232214115.

Abstract

A series of novel 1-(4-benzenesulfonamide)-3-alkyl/benzyl-hydantoin derivatives were synthesized and evaluated for the inhibition of eukaryotic and human carbonic anhydrases (CAs, EC 4.2.1.1). The prepared compounds were screened for their hCA inhibitory activities against three cytosolic isoforms as well as two β-CAs from fungal pathogens. The best inhibition was observed against hCA II and VII as well as Candida glabrata enzyme CgNce103. hCA I and Malassezia globosa MgCA enzymes were, on the other hand, less effectively inhibited by these compounds. The inhibitory potency of these compounds against CAs was found to be dependent on the electronic and steric effects of substituent groups on the N3-position of the hydantoin ring, which included alkyl, alkenyl and substituted benzyl moieties. The interesting results against CgNce103 make the compounds of interest for investigations in vivo as potential antifungals.

Keywords: carbonic anhydrase inhibitors; hydantoin; sulfonamides.

MeSH terms

  • Benzene Derivatives / chemistry
  • Benzene Derivatives / pharmacology
  • Benzenesulfonamides
  • Carbonic Anhydrase Inhibitors* / pharmacology
  • Carbonic Anhydrases* / metabolism
  • Eukaryotic Cells / enzymology
  • Eukaryotic Cells / metabolism
  • Humans
  • Hydantoins* / chemistry
  • Hydantoins* / pharmacology
  • Structure-Activity Relationship
  • Sulfonamides* / chemistry
  • Sulfonamides* / pharmacology

Substances

  • Carbonic Anhydrase Inhibitors
  • Carbonic Anhydrases
  • Hydantoins
  • Benzene Derivatives
  • Sulfonamides